A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study

BACKGROUND: Treatment of bipolar disorder (BD) usually requires drug combinations. Combinations of lithium plus valproic acid (Li/VPA) and lithium plus carbamazepine (Li/CBZ) are used in clinical practice but were not previously compared in a head-to-head trial. OBJECTIVE: The objective of this tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Missio, Giovani, Moreno, Doris Hupfeld, Demetrio, Frederico Navas, Soeiro-de-Souza, Marcio Gerhardt, dos Santos Fernandes, Fernando, Barros, Vivian Boschesi, Moreno, Ricardo Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815353/
https://www.ncbi.nlm.nih.gov/pubmed/31655626
http://dx.doi.org/10.1186/s13063-019-3655-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815353/
https://www.ncbi.nlm.nih.gov/pubmed/31655626
http://dx.doi.org/10.1186/s13063-019-3655-2

Ejemplares similares